Quick Answer
NIKA PHARMACEUTICALS, INC reported Common Stock Shares Outstanding of 1.05 billion shares for the year ending 2025.
- NIKA PHARMACEUTICALS, INC showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from NIKA PHARMACEUTICALS, INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), NIKA PHARMACEUTICALS, INC's Common Stock Shares Outstanding has grown by 7,834.2%.
- Historical annual values: Fiscal year 2025: 1.05 billion shares | Fiscal year 2024: 1.05 billion shares | Fiscal year 2023: 876.09 million shares | Fiscal year 2022: 876.09 million shares | Fiscal year 2021: 396.09 million shares | Fiscal year 2020: 13.20 million shares | Fiscal year 2019: 13.20 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: